書籍詳細

1. リンパ球の最近の進歩

P.19 掲載の参考文献

• 1) Nowell, P.C.:Phytohemagglutinin:an initiator of mitosis in cultures of normal human leukocytes. Cancer Res. 20:462, 1960.
  pubmed

• 2) Bain, B., Vas, M.R. and Lowenstein, L.:The development of large immature mononuclear cells in mixed leukocyte cultures. Blood 23:108, 196

• 3) Bach, F. and Hirschhorn, K.:Lymphocyte interaction:A potential histocompatibility test in vitro. Science, 143:813, 1964.
  pubmed

• 4) Miller, J.F.A.P.:Effect of neonatal thymectomy on the immunological responsiveness of the mouse, Proc. Roy. Soc. B. 156:415, 1962.

• 5) Miller, J.F.A.P. and Osoba, D.:Current concepts of the immunological function of the thymus. Physiol. Rev. 47:437, 1967.

• 6) Davies, A.J.S.:The thymus and the cellular basisof immunity. Transplant. Rev. 1:43, 1969.

• 7) Claman, H.N.and Chaperon, E.A.:Immunologic complementation between thymus and marrow cells. A model for the two-cell theory of immuncompetence. Transplant. Review. 1:92, 1969.

• 8) Miller, J.FA.P. and Mitchell, G.F.:Thymus and antigenreactive cells. Transplant. Rev. 1:3, 1969.

• 9) Miller, J.F.A.P.:Lymphocyte interactions in antibody response. Int. Rev. Cytol. 33:77, 1972.

• 10) Weber, W.T.:Avian B lymphocyte subpopulations. Origins and functional capacities. Transplant. Rev. 24:8, 1975.

• 11) Warner, N.L., Szenberg, A. and Burnet, F.M.:The immunological role of different lymphoid organs in the chicken. Aust. J. Exp. med. Sci. Biol. 40:373, 1962.

• 12) Cooper, MD., Peterson, R.D.A, South, M.A. and Good, R.A.:The functions of the thymus system and the bursa system in the chicken. J. exp. Med. 123:75, 1966.

• 13) Cooper, M.D., Keightley, R.G., Wu, L.Y.F.and Lawton, A.R.:Developmental defects of T and B cell lines in humans. Transplant. Rev. 16:51, 1973.

• 14) B?yse, E.A., Cantor, H., Shen, F.W.and McKenzie, J.F.C.:Nomenclature for antigens demonstrable on lymphocytes. Immunogenetics 5:189, 1977.

• 15) Silverstone, A.E., Rosenberg, N., Baltimore, D., Sato, V.L, Scheid, M.P. and Boyse, E.A.:Correlating terminal dexoynucleotidyl transferase and cell surface markers in the pathway of lymphocyte ontogeny. IN Differentiation of Normal and Neoplastic Hematopoietic cells. Clarkson, B., Marks, P.A. and Till, J.E., eds. Cold Spring Harbor Lab. 433, 1978.

• 16) Monette, F.C.:Antibodies against pluripotent stem cells. their use in studying stem cell function. Blood Cells 5:175, 1979.
  pubmed

• 17) Marshall, G.D. Jr., Low, T.L.K., Thurman, G.B.and Goldstein, A.L.:Recent advances in thymosin research. IN Human Lymphocyte Differentiation:Its Application to Cancer. Inserm Symposium 8, Serrou, B. and Rosenfield, C. eds. Elsevier, 271, 1978.

• 18) Gelfand, E.W., Dosch, H.M. and Shere, A.:The role of the thymus microenvironment in T cell differentiation. IN Hematopoietic Cell Differentiation. Golde, D.W., Cline, MJ., Metcalf, D. and Fox, C.F. eds. ICN-UCLA Symposia on Molecular and Cellular Biol. Vol. X. Academic Press, 277, 1978.

• 19) Nossal, G.J.V. and Pike, B.L.:Studies on the differentiation of B lymphocytes in the mouse. Immunology 25:33, 1973.

• 20) Raff, M.G., Megson, M., Owen, J.J.T. and Cooper, M.D.:Early production of intracellular IgM by B lymphocyte precursors in mouse. Nature 259:224, 1976.

• 21) Owen, J.J.T., Wright, D.E, Habu, S., Raff, M.C.and Cooper, M.D.:Studies on the generation of B lymphocytes in fetal liver and bone marrow. J. Immunol. 118:2067, 1977.

• 22) Gathings, W.E, Lawton, A.R.and Cooper, M.D.:Immunofluorescent studies of the davelopment of Pre-B cells, B lymphocytes and immunoglobulin isotype diversity in humans. Eur. J. Immunol. 7:804, 1977.
  pubmed

• 23) Owen, J.J.T., Jordan, R.K., Robinson, J.H., Singh, U. and Willcox, H.N.A.:In vitro studies on the generation of lymphocyte diversity. Cold Sprivg Harbor Symp. Quant. Biol. XLI, 129, 1977.

• 24) Osmond, D.G. and Nossal, G.J.V.:Differentiation of lymphocytes in mouse bone marrow. II. Kinetics of maturation and renewal of anti-globulin binding cells studied by double labeling. Cell. Immunol. 13:132, 1974.

• 25) Osmond, D.G.:Generation of B lymphocytes in the bone marrow. IN B Lymphocytes in the Immune Response. Cooper, M. D., Mosier, D.E., Scher, I. and Vitetta, E.S. eds. Eisevier, 63, 1979.

• 26) Rosse, C., Cole, S.B., Appleton, C., Press, O.W. and Clagett, J.:The relative importance of bone marrow and spleen in the production and dissemination of B lymphocytes. Cell. Immunol. 37:254, 1978.
  pubmed

• 27) Yoshida, Y. and Osmond, D.G.:Identity and proliferation of small lymphocyte precursors in cultures of lymphocyte-rich fractions of guinea pig bone marrow. Blood 37:73, 1971.
  pubmed

• 28) Yoshida, Y. and Osmond, D.G.:Homing of bone marrow lymphoid cells. Localization and fate of newly formed cells in lymphocyte-rich marrow fractions injections into lethally irradiated recipients. Transplnatation 25:246, 1978.
  pubmed

• 29) Nossal, G.J.V., Shortman, K., Howard, M. and Pike, B.L:Current problem areas in the study of B lymphocyte differentiation. Immunol. Rev. 37:187, 1977.

• 30) 吉田弥太郎, 内野治人:B細胞の産生と分化, 日本血液学全書第9巻, 丸善, pp. 159, 1981.

• 31) 吉田弥太郎, 朴英薫, 大久保直, 釜本隆行, 平岡篤信, 山岸司久, 内野治人: 膜表面性状からみたヒト骨髄リンパ球の分化, 臨床免疫, 13:624, 1981.

• 32) Greaves, M.F.and Janossy, G.:Patterns of gene expression and the cellular origins of human leukemias. Biochim. Biophys. Acta 516:193, 1978.

• 33) Greaves, M.F., Janossy, G., Francis, G. and Minowada. J.:Membrane phenotypes of human leukemic cells and leukemic cell lines. Clinical correlates and biological implications. IN Differentiation of normal and neoplastic hematopoietic cells. Clarkson, B., Marks, P.A.and Till, J.E. eds. Cold Spring Harbor Lab. 823, 1978.

• 34) Janossy, G, Greaves, M.F., Sutherland, R., Durant, J. and Lewis, C.:Comparative analysis of membrane phenotypes in acute lymphoid leukemia and in lymphoid blast crisis of chronic myeloid leukemia. Leukemia Res. 1:289, 1977.

• 35) Minowada, J.:Markers of human leukemia-lymphoma cell lines reflect hematopoietic cell differentiation. IN Human Lymphocyte Differentiation. Its Application to Cancer. INSERM Symposium No. 8 Serrou, B. and Rosenfield, C. eds. Elsevier, 337, 1978.

• 36) Nilsson, K. and Ponten. J.:Classification and biological nature of establishe dhuman hematopoietic cell lines. Int. J. Cancer 15:321, 1975.

• 37) Foon, K.A., Billing, R.J., Terasaki, P.I.and Cline, M.J.:Immunologic classification of acute lymphoblastic leukemia. Implications for normal lymphoid differentiation. Blood 56:1120, 1980.
  pubmed

• 38) Cantor, H. and Boyse, E.A.:Functional subclass of T lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T cell subclasses in a differentiation process independent of antigen. J. Exp. Med. 141:1376, 1975.

• 39) Katz, D.:Lymphocyte Differentiation, Recognition and Regulation. Academic Press, pp247, 1977.

• 40) 花岡正男:T細胞系の発生, 機能分化と増殖像, 日血会誌 40:873, 1977.

• 41) Gershon, R.K., Maurer, P.M. and Merryman, C.F.:A cellular basis for genetically controlled immunologic unresponsivene in mice. Tolerane induction in T cells. Proc. Nat. Acad. Sci. 70:250, 1973.

• 42) Eardley, D.D., Hugenberger, J., McVay-Boudreu, L, Shen, F.W., Geshon, R.K.and Cantor, H.:Immunoregulatory circuits among T-cell sets. I. Helper cells induce other T-cell sets to exert feedback inhibition. J.Exp. Med. 147:1106, 1978.

• 43) 藤本重義:担癌生体における抑制性T細胞 代謝16:1853, 1979.

• 44) Hellstrom, I. and Hellstrom, K.E.:Studies on cellular immunity and its serum-mediated inhibition in Moloney virus-induced mouse sarcomas. Int. J. Cancer 4:587, 1969.
  pubmed

• 45) Tada, T., Taniguchi, M. and David, C.S.:Properties of the antigen-specific suppressive T-cell factor in the regulation of antibody response of the mouse. IV. Special subregion assignment of the gene (s) that codes for the suppressive T-cell factor in the H2-histocompatibility complex. J. Exp. Med. 144:713, 1976.

• 46) Kiessling, R., Klein, E. and Wigzell, H.:Natural killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur. J. Immunol. 5:112, 1975.
  pubmed

• 47) Herberman, R.B., Bartram, S., Haskill, J. S., Nunn, M., Holden, H.T. and West, W.H.:Fc receptors on mouse effector cells mediating natural cytotoxicity against tumor cells. J. Immunol. 119:322, 1977.

• 48) Waldmann, T.A., Durm, M., Broder, S., Blackman, M., Blaese, R.M. and Strober, W.:Role of suppressor T cells in pathogensis of. common variable hypogammaglobulinemia. Lancet ii:609, 1974.

• 49) Wu, L.Y.F., Lawton, A.R. and Cooper, M.D.:Differentiation capacity of cultured B Iymphocytes from immunodeficient patients. J. Clin. Invest. 52:3180, 1973.

• 50) Moretta, L., Webb, S.R., Grossi, C.E., Lydyard, P.M. and Cooper, M.D.:Functional analysis of two human T-cell subpopulations. Help and suppression of B-cell responses by T cellsbearing receptors for IgM or IgG. J. Exp. Med. 146:184, 1977.
  pubmed

• 51) Grossi, B.E, Webb, S.R., Zicca, A., Lydyard, P.M., Moretta L., Mingari, M.C. and Cooper, M.D.:Morphological and histochemical analyses of two human T-cell subpopulations bearing receptors for IgM or IgG. J. Exp. Med. 147:1405, 1978.
  pubmed

• 52) Shirai, T., Hayakawa, K., Okumura, K. and Tada, T.:Differential cytotoxic effect of natural thymocytotoxic autoantibody of NZB mice on functional subsets of T cells. J. Immunol. 120:1924, 1978
  pubmed

2 悪性リンパ腫の病型

P.59 掲載の参考文献

• 1) Hodgkin, T:on some morbid appearances of the absorbent glands and spleen. Medico-Chirurgical Transactions 17:68-114, 1832.-Kaplan H.S. Hodgkin's Disease, Harvard Univ. Press, Cambridge Massachu- setts, 1972 より引用.

• 2) Wintrobe, MM.:Clinical Hematology, Lea & Febiger, philadelphia, 1967.

• 3) Kaplan, H.S.:Hodgkin's Disease, Harvard Univ. press, Cambridge Massachusetts, 1972.

• 4) Kundrat, H:Uber Lymphsarkomatose Wien. Wochenshr. 6:211-213, 1893.

• 5) Sternberg, C:Zur Frage des sog. Ewing. Tumor. Frank. Z. Path. 48:525-528, 1935.

• 6) Reed, D.M.:on the pathological changes in Hodgkin, s disease, with especial reference to its relation to tuberculosis. Johns Hopkins Hosp. Rep. 10:133-196, 1902.-3) より引用.

• 7) 木村禧代二:悪性リンパ腫の病態と臨床, 日本評論社, 東京, 1976.

• 8) John, A and Roman, B:Uber das Lymphosarcoma. Frankfurter Z. Path. 19:1-138, 1916.

• 9) 太田邦夫. 細網肉腫の病理学, 最新医学, 19(7). 1686-1692, 1964.

• 10) Brill, NE., Baehr, G. and Rosenthal, N:Generalized giant lymph follicle hyperplasis of lymphnodes and spleen. J.A.MA 84:668-671, 1925.

• 11) Symmers, D:Follicular lymphadenopathy with splenomegaly, A newly recognized disease of the lymphatic system. Arch. Path. 3:816-827, 1927.

• 12) Gall, E.A and Mallory J.B.:Malignant lymphoma, A clinical pathological survey of 618 cases. Am. J. Path. 18:381-429, 1942.

• 13) 赤崎兼義:悪性リンパ腫の概念, 最新医学, 19(7):1631-1648, 1964.

• 14) 赤崎兼義:網様内皮系統とその腫瘍, 日病会誌, 41:1-26, 1952.

• 15) Berard, C.W. & Dorfman, R.F.:Histopathology of Malignant Lymphomas, Clinics in Haematology 3(1):39-76, 1974.

• 16) Jones, S.E., Fuks, Z., Bull, M., Kadin, M.E., Dorfman, R.F., Kaplan, H.S., Rosenberg, S.A. and Kim, H.:non-Hodgkin's lymphomas IV. clinicopathologic correlation in 405 cases. Cancer 31:806-823, 1973.

• 17) Wintrobe, M. M:Clinical Hematology, Lea & Febiger, Phildelphia, 1974.

• 18) Stein, H., Kaiserling, E. and Lennert, K.:Evidence for B-cell origin of reticulum cell sarcoma. Virchow Arch. A. Path. Anat. and Histol. 364:51-67, 1974.

• 19) Braylan, R.C., Jaffe, E.S. and Berard, C.W.:Malignant lymphomas:current classification and new observations. Pathology Annual 10:213-270, 1975.
  pubmed

• 20) Elves, M.W.and Wilkinson, J.F.:Effect of PHA on the morphology of cultured leukocytes. Nature 194:1257-1259, 1962.

• 21) Lukes, R J., Taylor, C.R., Chir, B., Phil, D, Parker, J.W., Lincolin, T.L., Pattengale, P.K. and Tindle, B. H.:Amorphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias. Am. J. Pathol. 90:461-486, 1978.

• 22) 下山正徳, 湊啓輔, 木村禧代二:悪性リンパ腫-腫瘍細胞の膜性状からみた分類と病態生理学的特徴, 日本臨牀, 34(5):41-49, 1976.

• 23) 菊池浩吉, 石井良文, 小柴博文:T cell, B cell 白血病細胞の surface marker とリンパ増殖性腫瘍の分類, 日本臨牀 34(5):16-27, 1976.

• 24) 菊池浩吉, 山中昇, 小笠原実, 石井良文, 三國主税:リンパ球表面マーカーと悪性リンパ腫, 最新医学, 34(9):2025-2031, 1979.

• 25) Lennert, K, Stein, H. and Kaiserling, E:Cytological and functional criteria for the classification of malignant lymphomata. Br. J. Cancer 31, Suppl. II:29-43, 1975.

• 26) 山野利尚, 小阪昌明, 田村隆一, 沼田幸子, 高本雅弘, 右見正夫, 清水正樹, 白神峰, 三好和夫:リンパ腫におけるリンパ球の細胞内と細胞表面免疫グロブリン, 日本臨牀, 35(10):112-120, 1977.

• 27) 森尚義, 阿部正文, 小島瑞:免疫グロブリン産生能からみた悪性リンパ腫の検討, 最新医学, 34(9):2032-2038, 1979.
  Medical*Online

• 28) 三方淳男, 張ヶ谷健一, 鈴木裕, 大石隆男, 渡辺昌, 堤寛, 鈴木繁生, 影山 圭三, Non-Hodgkin 悪性リンパ腫の酵素組織化学, 最新医学, 34(9):2018〜2024, 1979.

• 29) 小島瑞, 今井大, 森尚義:濾胞性リンパ腫-特に胚中心発生の腫瘍の存在, 癌の臨床, 19(5):401-407, 1973.

• 30) 難波紘二:非ポジキン悪性リンパ腫の分類-Warrenton 会議のその後- 日本網内系学会誌, 17(1, 2):60-66, 1977.

• 31) 難波紘二:悪性リンパ腫研究の新段階, 悪性リンパ腫分類に関する Warren-ton会議の周辺, 日本網内系学会誌-15 (3):135-141, 1975.

• 32) 飯島宗一:悪性リンパ腫の分類-その現状と問題点, 最新医学, 34(9):2063- 2072, 1979.

• 33) Marchant, R.G., Hamlin, I, Lennert, K., Rilks, F., Stansfeild, A.G., and Unnik, J.A.M:Lancet I:406-408, 1974.

• 34) Lukes, R.J. and Collins, R.D.:Wew approaches to the classification of the lymphomata. Br. J. Cancer 31, Suppl. II:1-28, 1975.

• 35) 須知泰山, 若狭治毅, 三方淳男, 難波紘二, 菊池昌弘, 森茂郎, 毛利昇, 渡辺 昌, 社本幹博, 田島和雄, 張ヶ谷健一, 桐野有爾, 高木敬三, 福永真治, 板垣哲朗, 松田幹夫:非ポジキンリンパ腫病理組織診断の問題点-新分類の提 案, 最新医学, 34(9):2049-2062, 1979.

3 ホジキン病―診断から治療―

P.87 掲載の参考文献

• 1) Wintrobe, M.M.:Conditions chiefly affecting lymph nodes and spleen. Clinical Hematology, Lea & Febiger, Philadelphia. 1974.

• 2) Hodgkin, T.:On same morbide appearance of the absorbed glands and spleen. Medicochirug. Trans. (London), 17:68, 1832.

• 3) Wilks, S.:Cases of lardaceous disease and some allied affections. Guy's Hosp. Rep. 2:103, 1856.

• 4) Lukes, RJ.:The American concept of malignant lymphoma. 最新医学, 19:1631, 1964.

• 5) Jackson, H. Jr. and Parker, FJr.:Hodgkin's disease and allied disorder. Oxford Univ. Press, N. Y. 1947.

• 6) Lukes, RJ., Butler, J.J. and Hicks, E. B.:Natural history of Hodgkin:s disease as related to its pathologic picture. Cancer 19:317, 1966.

• 7) Lukes, R.J. et al.:Report of the nomenclature committece. Cancer Res. 26:1311, 1966.

• 8) Ultmann, JE. and DeVita, V.T. Jr.:Hodgkin's disease and other lymphomas, in Isselbacher, K.J. et al. edited Harrison's Principles of internal medicine, Ninth Edit. McGraw-Hill, N.Y. p.1633, 1980.

• 9) Kaplan, H.S.:The radical radiotherapy of regionally localized Hodgkin's dasease. Radiology 78:553, 1962.

• 10) Kaplan, H.S.:Clinical evaluation and radiotherapeutic management of Hodgkin's disease and the malignant lymphoma. N. Engl. J. Med. 287:892, 1968.

• 11) Rosenberg, S.A. and Kaplan, H, S.:Hodgkin's disease and other malignant lymphomas. Calif. Med. 113:23, 1970.
  pubmed

• 12) Clinical drug evaluation program:A general protocol for the phase II study of cancer chemotherapeutic agents in malignant solid tumors. Cancer chemotherapy Rep. 52:650, 1968.

• 13) Karnofsky, D.A.:Meaningful clinical classification of therapeutic responses to anticancer drugs. Clinical Pharmacol. Therap. 2:709, 1961.

• 14) 木村禧代二他:悪性リンパ腫の化学療法-Bleomycinの効果を中心に-. 日本臨牀 27:1593, 1969.
  Medical*Online

4 非ポジキン・リンパ腫―リンパ肉腫・リンパ節細網肉腫・巨大濾胞性リンパ節腫―

P.127 掲載の参考文献

• 1) 小島瑞:「Non-Hodgkin リンパ腫の病理」の司会者のことば, 最新医学, 34:2016, 1979.
  Medical*Online

• 2) Wintrobe, M.M.:Conditions chiefly affecting lymph nodes and spleen. Clinical Hematology, Lea & Febiger, Philadelphia, p. 1099, 1967.

• 3) 木村禧代二:悪性リンパ腫の歴史と分類. 悪性リンパ腫の病態と臨床, p3, 日本評論社, 東京, 1976.

• 4) 難波紘二,板垣哲朗, 飯島宗一:悪性リンパ腫病型分類の意義と問題点. 日本臨牀, 35:3664, 1977.
  Medical*Online

• 5) 飯島宗一:悪性リンパ腫の分類-その現状と問題点. 最新医学, 34:2063, 1979.
  Medical*Online

• 6) Pincus, T. Hartley, J.W., Rowe, W.P.:A major genetic focus affecting resistance to infection with murine leukemia viruses. I. Tissue. culture studies of naturally occuring viruses. J. Exp. Med., 133:1291 1971.

• 7) East, J.:Immunopathology and neoplasms in New Zealand Black (NZ-B) and STL/J mice. Prog. Exp. Tumor Res., 13:84, 1970.

• 8) Kaplan, H.S., Goodenow, R.S., Epstein, AL., Gartner, S., Decleve, A., Rosenthal, P.N.:Isolation of a type C RNA virus from an established human histiocytic lymphoma cell line. Pro. Natl. Acad. Sci., 74:2564, 1977.

• 9) Louie, S., Schwartz, S.:Immunodeficiency and pathogenesis of lymphoma and leukemia. Seminars in Hematology, 15:117, 1978.

• 10) Rausing, A., Trell, E.:Malignant lymphogranulomatosis and anticonvulsant therapy. Acta Med. Scand., 189:131, 1971.
  pubmed

• 11) 福原資郎, 白川茂, 内野治人:染色体分染解析からみた悪性リンパ増殖性疾患-14q 転座 (14q+マーカー) の意義. 最新医学, 34:1283, 1979.
  Medical*Online

• 12) 瀬木三雄:悪性リンパ腫の統計, 最新医学, 19:1788, 1964.

• 13) 脇坂行一:内科疾患の変遷, 日内会誌, 65:1, 1976.

• 14) 難波紘二,原弘, 飯島宗一:広島地方における悪性リンパ腫の実態. 日網会 誌, 17:144, 1977.

• 15) 市丸道人:T cell 悪性リンパ腫の臨床, 日内会誌, 70:511, 1981.

• 16) Gall, E.A., Mallory, TB.:Malignant Iymphoma:A clinicopathologic survey of 618 cases. Am. J. Pathol., 18:381, 1942.

• 17) Rappaport, H.:Tumors of the hematopoietic system. Atlas of tumor pathology, sect. 3, fasc. 8, Armed Forces Instutute of Pathology, Washington, D.C., 1966.

• 18) 赤崎兼義:網内系腫瘍. 日血全書, 第5巻, 白血病及類縁疾患, 丸善, p. 386, 1962.

• 19) 難波紘二:非ポジキン悪性リンパ腫の分類-Warrenton 会議その後-, 日網会誌, 17:59, 1977.

• 20) Nathwani, B.N., Kim, H., Rappaport, H.:Malignant Iymphoma, lymphoblastic. Cancer, 38:964, 1976.

• 21) Lukes, RJ., Collins, D.:Immunologic characterization of human malignant lymphomas. Cancer, 34:1488, 1974.

• 22) Lukes, RJ.:Functional classification of malignant lymphoma of Lukes and Collins. Recent Results Cancer Res., 64:19, 1978.

• 23) Lukes, RJ., Lincoln, T.L., Parker, J.W., Alavaiko, MJ.:An immunologic approach to classification of malignant lymphomas:A cytokinetic model of lymphoid neoplasia. Differentiation of Normal and Neoplastic Hematopoietic cells. Clarkson, B., Marks, P. A., Till, J.E. eds. P. 935, Cold Spring Harbor Laboratory, 1978.

• 24) Gerard-Marchant, R., Hamlin, I., Lennert, K., Rilke, F., Stansfeld, A. G., Unnik, G.A.M.:Classification of non-Hodgkin's lymphomas. Lancet, 11:405, 1974.

• 25) Lennert, K.:Malignant Lymphomas. Hb. d. spez. Path. 1/3B, Springer-Verlag, New York, 1978.

• 26) Suchi, T., Tajima, K., Nanba, K., Wakasa, H., Mikata, A., Kikuchi, M., Mori, S., Watanabe, S., Mohri, N. Shamoto, M., Harigaya, K., Itagaki, T., Matsuda, M.:Some problems on the histopathological diagnosis of non-Hodgkin's malignant Iymphoma-a proposal of a new type-Acta Path. Jap., 29:755, 1979.

• 27) 須知泰山, 若狭治毅, 三方淳男, 難波紘二, 菊地昌弘, 森茂郎, 毛利昇, 渡 辺昌, 社本幹博, 田島和雄, 張ヶ谷健一, 桐野有爾, 高木敬三, 福永真治, 板垣哲朗, 松田幹夫:非ポジキンリンパ腫病理組織診断の問題点-新分類の提案. 最新医学, 34:2049, 1979.

• 28) 難波紘二:私信

• 29) Rappaport. H., Winter, W.J., Hicks, EB.:Follicular lympoma;A re-evaluation of its position in the scheme of malignant lymphoma based on a suvuey of 235 casas. Carcer, 9:792, 1956.

• 30) Lennert, K.:Follicular lymphoma. A tumor of the germinal centers. GANN Monograph on Cancer Research, 15:217, 1973.

• 31) Kojima, M., Imai, Y., Mori, N.:A concept of follicular lymphoma. Aproposal for existence of a neoplasm originating from the germinal center, GANN Monograph on Cancer Research, 15:195, 1973.

• 32) Burkitt, D.P.:Asarcoma involving the jaws in African children, Brit. J. Surg., 46:218, 1958.

• 33) Berard, C.W., O, Conor, G.T., Thomas, LB., Torloni, H.:Histopathological definition of Burkitt:s tumor. WHO Bull., 40:601, 1969.

• 34) Epstein, M.A., and Barr, Y.M.:Cultivation in vitro of human lymphoblasts from Bukitt:s malignant lymphoma. Lancet, 1:252, 1964.

• 35) 白川茂, 内野治人:悪性リンパ腫の臨床症状および診断. クリニカ, 4:764, 1977.

• 36) 衣笠恵士:悪性リンパ腫. 新内科学大系, 51, 血液・造血器疾患III, 中山書店, p. 212, 1979.

• 37) Ahmann, D.L., Kiely, J.M.:Malignant lymphoma of the spleen:A review of 49 cases in which the disagnosis was made at splenectomy. Cancer, 19:461, 1966.

• 38) Lewin, K.J., Ranchod, M., Dorfman, R.F.:Lymphomas of the gastrointestinal tract. A study of 117 cases presenting with gastrointestinal disease. Cancer, 42:693, 1978.
  pubmed

• 39) Kadin, M.E., Bensch, K.G.:On the origin of Ewing tumor. Cancer, 27:257, 1971.
  pubmed

• 40) Thierfelder, S., Rodt, H., Thiel, E. (eds):Immunological Diagnosis of Leukemias and Lymphomas. Springer-Verlag, New York, 1977.

• 41) Pinkus, G.S., Said, J.W.:Chracterization of non-Hodgkin's lymphomas using multiple cell markers. Immunolologic, morphologic, and cytochemical studies of 72 cases. Amer. J. Path., 94:349, 1979.

• 42) Lukes, RJ.:Classification of lymphomas. (Lecture) Abstrcts 18 th Congress of International Society of Hematology, Montreal, P. 56, 1980.

• 43) Shirakawa, S., Nishikori, M., Tatsumi, E., Uchino. H.:Non-Hodgkin's lymphoma-lmmunopathophysiological aspects in comparison with Hodgkin's lymphoma. Recent Advances in RES Research, 16:131, 1976.

• 44) 白川茂, 巽英二, 滝内鳩子, 堂前尚親, 植原典美, 内野治人:細胞性免疫異 常および不全と内科疾患-リンパ増殖性疾患-日本臨牀, 36:985, 1979.

• 45) Carbone, P.P., Kaplan, H.S., Musshoff, K., Smithers, D.W., Tubiana, M.:Report of the committee on Hodgkin's disease staging classifica, tion. Cancer Res., 31:1860, 1971.

• 46) 山下久雄,大蔵丈太郎, 吉岡達也, 渡部恒也:悪性リンパ腫のStage分類とその問題点. 臨牀放射線, 18:877, 1973.

• 47) Canellos, G.P., Lister, T.A., Skarin, A.T.:Chemotherapy of the non-Hodgkin's lymphomas. Cancer, 42:932, 1978.
  pubmed

• 48) Mathe, G., Seligmann, M., Tubiana, M. (eds.):Lymphoid neoplasias II Clinical and therapeutic aspects. Springer-Verlag, New York, 1978.

• 49) 内野治人:悪性リンパ腫. 43:1258, 1979.

• 50) 坂野輝夫:Non-Hodgkin リンパ腫の現況と将来における諸問題, III. Non- Hodgkin リンパ腫の化学療法について. 臨床血液, 22:159, 1981.

5. リンパ性白血病

P.147 掲載の参考文献

• 1) Siegal, F.P., Fillipa, D.A. and Koziner, B:Surface markers in leukemia and lymphomas. Am. J. Path. 90:451-459, 1978.

• 2) Mann, R. B., Jaffe, ES. and Berard, C.W.:malignant ymphomas-A conceptual understanding of morphologic diversity, Am. J. Path. 94:104-191, 1979.

• 3) Berard, C.W., Greene, M.H., Jaffe, E.S., Magrath, I., and Ziegler, J,:Amultidisciplinary approach to non-Hodgkin's lymphomas. Ann. Int. ern. Med. 94, 218-235, 1981.

• 4) Nakahara, K., Ohashi, T., Oda, T., Hirono, T., Kasai, M., Okumura, K. and Tada, T.:Asialo GM1 as a cellsurface marker detected in acute lymphoblastic leukemia. N. Engl. J. Med. 302:674-677, 1980.

• 5) Uchiyama, T., Yodoi. J., Sagawa, K., Takatsuki, K. and Uchino, H.:H.:Adult T-cell leukemia:Clinical and hematologic feature of 16 cases. Blood, 50:481-492, 1977.

• 6) Kohler, G. and Milstein, C.:Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495-497, 1975.
  pubmed

• 7) 高月清, 内山卓, 服部俊夫, 和野雅治, 通堂満:モノクロナール抗体による白血病細胞の解析, 癌と化学療法 8:1184-1199, 1981.

• 8) Reinherz, E.L., Kung, P.C., Goldstein, G., Levey, R.H., and Schlossman, S.F.:Discrete stages of human intrathymic differentiation:analysis of normal thymocytes and leukemic lymphoblast of T-cell lineage. Proc. Natl. Acad. Sci. USA 77:1588〜1592, 1980.

• 9) Reinherz E.L. and Schlossman, S.F.:Regulation of the immune response inducer and suppressor T-lymphocyte subsets in human beings. New Eng J. Med 303:370〜373, 1980.

• 10) Reinherz, E.L. and Schlossman, S.F.:The differentiation and function of human T lymphocytes. Cell 19:821〜1827, 1980.

• 11) Reinherz E.L., Kung, P.C., Pesando, J.M., Ritz, J., Goldstein, G. and Schlossman, S.F.:Ia determinants on human T-cell subsets defined by monoclonal antibody. J Exp. Med, 150:1472〜11482, 1979.

• 12) Eisenbarth G.S. Haynes, B.F., Schroer, J.A. and Fauci, A.S.:Production of monoclonal antibodies reacting with peripheral blood mononuclear cell surface differentiation antigens. J. Immunol. 124:1237, 1980.
  pubmed

• 13) Wang, C.I., Good, R.A., Evans, R.T. et al.:Identification of a P. 69,71 complex expressed on human T cells sharing determinants with B-type chronic lymphatic leukemia cells, J. Exp. Med. 151:1539〜11544, 1980.

• 14) Ledbetter, J.A., Evans, R.L, Lipinshi, M. ef al:Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man. J. Exp. Med. 153, 310〜323, 1981.

• 15) Uchiyama T. Broder, S. and Waldmann, T.A. A monoclonal antibody (anti-Tac) reactive with activated and functioually mature human T cells. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J. Immunol. 126:1393〜1397, 1981.

• 16) Uchiyama, T., Nelson, D.L., Fleisher, T.A. and Waldmann, T.A.:A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. II. Expression of Tac antigen on activated cytotoxic killer T cells, suppressor cells, and on one of two types of helper T cells. J. Immunol. 126:1398〜1408, 1981.

• 17) Boumsell L. Bernard, A. Reinherz, E'L. et al:Surface antigens on malignant Sezary and T-CLL cells correspond to those of mature Tcells Blood. 57:526〜530, 1981.

• 18) Kung, P.C. Berger, C.L, Goldstein, G.:Cutaneous T cell lymphoma:Charcterization by monoclonal antibodies. Blood. 57:261〜266, 1981.

• 19) Hattori T. Uchiyama, T., Toibana, T., Takatsuki, K. and Uchino, H.:Differentiation of adult T cell leukemic cells in Japan to functionally mature and activated T cells in vitro. Blood. 58:645〜647, 1981.

• 20) Broder. S. Edelson, R.L., Lutzner, M.A. et al.:The Sezary syndrome:A malignant proliferation of helper T cells. J. Clin. Invest. 58:1297〜1306, 1976.

• 21) Uchiyama T. Sagawa. K., Takatsuki, K. and Uchino, H.:Effect of adult T-cell leukemia cells on pokeweed mitogen-induced normal B-cell differentiation. Clin Immunol. Immunopathol. 10:24〜34, 1978.

• 22) Broder S. Uchiyma, T., Waldmann, T.A. et al:Activation of leukemic fro-suppressor to become suppressor cells by cooperating normal Tcells. New Eng. J. Med. 304:1382〜1387, 1981.

6. 骨髄腫タンパクの産生機序と免疫不全

P.172 掲載の参考文献

• 1) Natvig, J.B. & Kunkel, H.G.:Adv. Immunol. 16:1-60, 1973.
  pubmed

• 2) Hangartner, H:Proc. Nat. Acad. Sci. 75:4494, 1978.

• 3) Croce, C.M., Shander, M., Martinis, J., Cicurel, L, D:Ancona, G.G., Dolby T.W. & Koprowski, H.:Proc. Nat. Acad. Sci. 76:3416-19, 1979.
  pubmed

• 4) Sakano, H., Huppi, K., Heinrich, G., Tonedawa, S.:Nature 280, 288-294, 1979, 286, 676-683, 1980.

• 5) Davis, MM., Calame, K., Early, P.W., Livant, D. L Joho, R., Weissman, I.L, Hood, L.:Nature 283:733, 1980,
  pubmed

• 6) Honjo, T. & Kataoka, T.:Proc. Natl. Acad. Sci. 75:2140, 1978, 77:919, 1980.

• 7) Yaoita, Y. & Honjo, T.:Natnre, 286:850-853, 1980.
  pubmed

• 8) Raffit, T.H., Forster, A. Dunnick, W. & Beutley, D.L.:Nature 283:351-356, 1980.

• 9) Redbruch, A., Lisegang, B. & Rajewsky, K.:Proc. Natl. Acad. Sci., 77:2909-2913, 1980.

• 11) Early, P., Rogers, J:, Davis, M., Calame, K-Bond, M., Wall, R., & Hood, L.:Cell, 20:313, 1980.
  pubmed

• 12) Shinoda, T., Takahashi, N., Takayasu, T., Okuyama, T. & Shimizu, A:Proc. Nat. Acad. Sci. in press.

• 13) Vitetta, E.S. & Uhr, J.W.:Immunol. Rev. 37:50-88, 1977.
  pubmed

• 14) Tonegawa, S., Maxam, A.M., Tizard, R., Berhard, O. & Gilbert, W.:Proc. Natl. Acad. Sci. 75:1485-1489, 1978.

• 15) Putnam F.W.:The Plasma Proteins, III:65-76, Academic, Press 1977.

• 16) Nakanishi, I., Kajikawa, K., Migita, S., Mai, M., Akimoto, R. & Mura, T.:Cancer Research, in press.

• 17) 右田俊介:ヘキスト Immuroreview 表紙, 16 No.2 1981.

• 18) Cook, W.D. & Scharff, M D., Proc. Natl. Acad. Sci., 74:5687-5691, 1977.
  pubmed

• 19) Stott, D.I.:Biochem. J., 130:1151-1152, 1972.
  pubmed

• 20) Baumal, R. & Scharff, MD.:J. Immunol., 116:65-74, 1976.
  pubmed

• 21) Preudhomme, J.L., Labaume, S.& Praloran, V.:Blood 55:1136-1140, 1980.

• 22) Franklin, E.C.:New Engl. J. Med. 294:531-537, 1976.
  pubmed

• 23) Sakano, H., Rogers, J.H., Huppi, K., Brack, C., Traunecker, A., Maki, R. Wall, R. & Tonegawa, S.:Nature 277:627-633, 1979.
  pubmed

• 24) Adlersberg, J.B., Grann, V., Z-Franklin, D., Frangione, B. & Franklin, E.C.:Blood 51:85-96, 1978.

• 25) Bernier, G.M., Fanger, M.W.:Proteides Biol. Fluid 25:903, 1978.

• 26) Sakurabayashi, I. Kin, K. & Kawai, T.:Blood, 53:269-278, 1979.
  pubmed

• 27) Spiegelberg, H.L. & Fishkin, B.G.:J. Clin. Invest. 58:1259-1265, 1976.
  pubmed

• 28) Robinson, E.A. & Appella, E.:J. Biol. Chem., 254:11418-11430, 1979.
  pubmed

• 29) Kenter, A.L. & Birshtein, B. K.:Science 206:1307-1309, 1979.
  pubmed

• 30) Tucker, P.W., Marcu, K. B., Newell, N., Richards, J. & Blattner, F.B.:Science, 206:1303-1306, 1979.

• 32) Caggiano, V., Dominguez, C., Opfell, R.W., Kochwa, S & Wasserman, L. R.:Amer. J. Med. 47:978-985, 1969.
  pubmed

• 33) Weatherall, DJ. & Clegg, J. B.:Cell. 16:467, 1979.
  pubmed

• 34) Werner, B.G. & Sternberg, A. G.:Immunogen. 3:254, 1974.

• 35) Francus, T. & Birshtein, B.K.:Biochem. 17:4324-4331, 1978.

• 36) Birshtein, BK. Campbell, R & Greenberg M.L.:Biochem. 19:1730-1737, 1980.

• 37) Wang, A.C., Wang, I.Y.F., Mc Cormick, J.N. & Fudenberg, H.H.:Immunochem, 6:451, 1969.

• 38) Wang, A.C., Wilson, SK, Hopper, J.E, Fudenberg, H.H. & Nisonoff, A.:Proc. Natl. Acad. Sci., 66:337, 1970, 66:657, 1970.

• 39) Todel, C.W., Franklin, E.C. & Rudders, R.A.:J. Immunol. 112:871-876, 1974.

• 40) Pruzanski, W., Underdown, B., Silver, E.H. & Katz, A.:Amer. J. Med. 57:259-266, 1974.
  pubmed

• 41) Yagi, Y., Silverman, A.Y. & Pressman, D.:J. Immunol. 110:335-342, 1973, 343-349, 1973, 350-353, 1973.

• 42) Fateh-Moghadam, A., Beil, E., Borchers, H, Asamer, H. & Raab, Ch.:Blut, XXI, 146-154 (1970).

• 43) Fair, D.S., Schaffer, S.& Krueger, R.G.:J. Immunol. 117:944-949, 1976.
  pubmed

• 44) Hopper, J.E, Haren, J.M. & Kmiecik, T.E.:J. Immunol. 122:2000-2006, 1979.
  pubmed

• 45) Rudders, RA, Yakulis, V. & Heller. P.:Amer, J. Med. 42:630-635 1967, 55:215-221, 1973.

• 46) Oriol, R, Bouvet, J.P. & Liacopoulos, P.:Immunol. 27:1081-1093, 1095-1101, 1974.

• 47) Sarasombath, S., Mestecky, J. & Skvaril, F.:Clin. Exp. Immunol. 29:67-74, 1977.
  pubmed

• 48) Hopper, JE. Noyes, C. Heinrikson, R. & Kessel, J.W.:J. Immunol., 115:1101-1107, 1975, 116:743-746, 1976.

• 49) Morse, H.C., Lieberman, R., Lawton III, A.R., Potter, M. & Asofsky, R.:J. Immunol. 117:541, 1976, 118:1682, 1977, 124:541-547, 1980.

• 50) 右田俊介:ヘキスト Immunoreview 表紙, 15:No.6, 1980.

• 51) 星崎東明, 桂 邦夫, 仁木洋子, 馬場百合, 佐々木正道, 高丘 恵:日血会誌, 44:477, 1981.

• 52) Goldroosen, M.H., Pruzanski, W. & Freedman, M.H.:Immunochem. 9:387-404, 1972.

• 53) Hobbs, J.R.:Brit, Med. J., 16:699, 1967.

• 54) Lindstrom, F.D., Hardy, W.R., Eberle, BJ. & Williams, R.C.:Ann. Int. Med., 78:837-844, 1973.
  pubmed

• 55) Fine, J.M., Lambin, P. & Muller, J.Y.:Acta Med. Scand., 205:339-341, 1979.
  pubmed

• 56) Axelsson, U.:Acta Med. Scand. 201:173-175, 1977.
  pubmed

• 57) Kyle, R.A.:Am. J. Med. 64:814-826, 1978.
  pubmed

• 58) Axelsson, U., Bachman, R. & Haller, J.:Acta Med. Scand., 179:235-247, 1966.

• 59) Soloman, A.:Amer. J. Med:, 63:169-176, 1977.

• 60) Radl, J.:Clin, Immunol. Immunopath.:14:251-255, 1979.

• 61) 坂井俊之助, 右田俊介:日本癌学会32回総会記事, 248, 1973.

• 62) Lynch, R.G., Rohrer, J.W., Odermatt, B., Gebel, H.M., Autry, J.R. & Hoover, R.G.:Immunol, Rev. 48:45-80, 1979.
  pubmed

• 63) Leibson, P.J., Loken, M.R., Panem, S. & Schreiber, H.:Prouc., Natl., Acad. Sci., 76:2937-2941, 1979.

• 64) Meyers, B.R., Hirschman, W.Z. & Axelrod, J.A.:Amer. J. Med., 52:87-92, 1972.

• 65) Cone, L. & Uhr, J.W.:J. Clin, Invest. 42:2241-2248, 1964.

• 66) 筑田孝司:金沢大学十全医学会雑誌, 87:52-69, 1978.
  Medical*Online

• 67) Waldmann, TA, Blaese, R.M., Broder, S. & Krakauer, R. S.:Ann. Intern. Med. 88:226, 1978.
  pubmed

• 68) Karle, H., Hansen, N.E. & Plesner, T.:Scand. J. Haematal. 17:62-70, 1976.
  pubmed

• 69) Chen, Y., Bhoopalam, N., Yakulis, V. & Heller, P.:Ann. Intern, Med., 83:625-631, 1975.
  pubmed

• 70) Heller, P.:Blut, 37:65-68, 1978.
  pubmed

• 71) Tsukuda, K, Tsukuda, Y. & Klein, G:Cell. Immunol. 60:191, 1981.
  pubmed

• 72) Tsukuda, K., Berczi, I. & Klein, G:Cell. Immunol. in press.

• 73) Kafzmann, J.A.:J. Immunol, 121:1405-1409, 1978.

• 10a) 高橋直樹, 木庶 佑:蛋核酵, 26:298-303, 1981.

• 10b) Adms, J.M.:Immunology Today 1:10-17, 1980.

• 31a) Tokuyama, H. Migita, S. & Ujiwara, M:Ann. Rep. Cancer Inst. Kanazawa Univ. 3:1-13, 1969.

• 31b) Karlsson, F.A., Peterson. P.A. & Berggard. I:Proc. Natl. Acad. Sci. 64:1257-1263, 1969.

7. 骨髄腫と類縁疾患

P.211 掲載の参考文献

• 1) シンポジウム「Bcell malignancy-その臨床と病理」 (今村幸雄, 星野 孝 司会) 臨床血液 21(10):1456〜1518, 1980.

• 2) 厚生省大臣官房統計調査部編:人口動態統計 (昭25年度〜昭53年度), 厚生省統計協会.

• 3) WHO, World Health Statistics Report 18:430, 1965:20 (12), 1967 23 (3), 1970:25 (4, 5), 1972:26 (7, 8), 1973.

• 4) 加納 正:わが国における骨髄腫, 綜合臨牀 22(8):1601-1607, 1973.

• 5) 今村幸雄:骨髄腫-死亡統計による疫学的検討-医学のあゆみ 90(9):670- 678, 昭49.

• 6) 日野志郎:骨髄腫細胞の光顕と細胞化学. 骨髄腫のすべて (三好和夫編), 84-93, 南江堂, 昭53.

• 7) Pietschmann et al:Zytochemische Untersuchungen von Myelomzellen. Folia Haematol. (Leipzig) 99:131-143, 1973.

• 8) 島峰徹郎, 丹下 剛:骨髄腫の病理, 骨髄腫のすべて (三好和夫編), 73-83, 南江堂, 昭53.

• 9) 今村幸雄, 桃井宏直, 三好和夫:日本における骨髄腫-日本文献及び私信により集めた309例の臨床ならびに血液学的統計観察-日本臨牀 20(1):117 〜146, 昭37.

• 10) 今村幸雄, 戸川敦:骨髄腫にみられたtetramer型Bonce Jones蛋白についての観察, 日血会誌 35(3):392-393, 1972.

• 11) Wieme:Agar gel electrophoresis, Elsevier, Amsterdam 1965.

• 12) Putnam, F.W. et al:The heat precipitation of Bence Jones proteins. I. Optimum conditions. Arch. Biochem. Biophys. 83:115-130, 1959.
  pubmed

• 13) Cohen et al:Detection of urinary Bence Jones protein by means of p-toluene sulfonic acid (T.S.A.) Am. J. Clin. path. 37 (6):660-663, 1962.

• 14) Potter, M. editor:Progress in myeloma Elsevier, North-Holland, 1980.

• 15) 沼田幸子ほか:免疫グロプリンのL鎖とその型 κ/λ比. 骨髄腫のすべて (三好和夫編), 227-241, 南江堂. 昭53.

• 16) Arend, W.P. et a l:Nonsecretory myeloma:immunofluorescent demonstration of paraprotein within bone marrow plasma cells. Cancer 33:721-728, 1974.

• 17) 清水 勝ほか:2峰性のIgG を呈した1症例. 日血会誌 30(2):276-285, 昭42.

• 18) Joyner, M.V. et al:Non-excretory multiple myeloma. Brit. J. Haematol. 43:559-566, 1979.

• 19) Bouvet, J.P. et al:Two myeloma globblins IgG1-k and IgG1-λ from asingle patient. II. Their common cellular origin as revealed by immunofluoresence studies. Immunology 27:1095-1101, 1974.

• 20) Wolfenstein-Todal, C. et al:Similarities of the light chains and the variable regions of the heavy chains of the IgG2λ and IgA1λ myeloma proteins from a single patient. J. Immunol. 112:871〜876, 1974

• 21) Kyle, R. A.:Multiple myeloma. Review of 869 cases. Mayo Clinic Proceedings 50:29-40, 1975.
  pubmed

• 22) Lewis, A.F. et al:An atypical immunoglobulin. Blood 32:189-204, 1968.
  pubmed

• 23) Hobbs, J.R. et al:A half-molecule Gκ plasmacytoma. Clin. exp. immunol. 5:199-207, 1969.

• 24) 戸川 敦, 今村幸雄:Bence Jones 蛋白に関する研究. 第1報K型 tetrame-ric Bence Jones型骨髄腫にみられた異常蛋白の研究. 日血会誌 38:571- 581, 1975.

• 25) 佐藤幹二ほか:血中及び尿中にDimer型及びTetramer型Bence Jones蛋白を呈したmultiple myelomaの一剖検例. 臨床血液 16:620-627, 1975.

• 26) 今村幸雄:異常免疫グロブリンとその臨床的意義. 臨床血液 17:821-831, 1976.

• 27) 阿部光俊, 今村幸雄:骨髄腫の骨変化. 骨髄腫のすべて (三好和夫編) 153-164, 南江堂, 昭53

• 28) Jocobson, H.G. et al:Vertebral pedicle sign:a roentgen findings to differentiate metastatic carcinoma from multipe myeloma. Am. J. Raentogenol. & Rad. Therapy. 80:817-821, 1958.

• 29) Mundy, GR. et al:Evidence for the secretion of an osteoclast stimulating factor in myeloma. N. Engl. J. Med 291:1041-1046, 1974.
  pubmed

• 30) Spitler, L.E. et al:Phagocytes and C4 in paraproteinemia. Brit. J. Haematol. 29:279-292, 1975.

• 31) Karle, H. et al:Neutrophil defect in multiple myeloma:Studies on intraneutrophilic lysozyme in multiple myeloma and malignant lymphoma. Scand. J. Haematol 17:62-70, 1976.
  pubmed

• 32) Abdou, N.I. et al:The monoclonal nature of lymphocytes in multiple myeloma:Effect of therapy. Ann. Intern. Med. 83:42-45, 1975.
  pubmed

• 33) Wurster-Hill, D.H. et al:Chromosome studies in myelomatosis. Virchows Arch. B cell path. 29:93-97, 1978.

• 34) 今村幸雄. 骨髄腫と免疫不全. 現代医療 12. 1715-1723, 1980.

• 35) Mellstedt, H. et al:Monoclonal lymphocyte population in human plasma cell myeloma. Clin. exp. Immunol. 17:371-384, 1974.
  pubmed

• 36) Anday, GJ. et al:Cytogenetic studies in multiple myeloma. J. Nat. Cancer Inst. 52:1069-1079, 1974.
  pubmed

• 37) Mackenzie, M.R. et al:Multiple myeloma:an immunologic profile. J. Immunol. 118:1864-1871, 1977.
  pubmed

• 38) Ziegler, JB. et al:Leukocyte function in paraproteinemia. Aust. NZ. J. Med. 5:39-43, 1975.

• 39) Kyle, R.A. et al:The monoclonal gammopathies. Multiple myeloma and related plasma cell disorders. Charles C. Thomas. Publ., 1976.

• 40) Mackenzie, M.R. et al:The hyperviscosity syndrome. I. In IgG myeloma:The role of protein concentration and molecular shape. J. Clin. Invest. 49:15〜20, 1970.

• 41) Bloch, KJ. et al:Hyperviscosity syndromes associated with immunoglobulin abnormalities. Semin. Hematol. 10:113-124, 1973.
  pubmed

• 42) Capra, J.D. et al:Aggregation of γ3 proteins:Relevance to the hyperviscosity syndrome. J. Clin. Invest. 49:610-621, 1970.

• 43) Pruzanski, W. et al:Leukemic form of immunocytic dyscrasia (plasma cell leukemia):a study of ten cases and a review of the literature. Am. J. Med. 47:60-74, 1969.

• 44) Kyle, R.A. et al:Plasma cell leukemia:report on 17 cases. Arch, Int. Med. 133:813-818, 1974.

• 45) 小川哲平:形質細胞性白血病. 骨髄腫のすべて (三好和夫編) 263-270, 南江堂, 昭53.

• 46) Kyle, R.A. et al:smoldering multiple myeloma. N. Engl. J. Med. 302:1347-1349, 1980.
  pubmed

• 47) Alexanian, R.:Localized and indolent myeloma. Blood 56:521-525, 1980.
  pubmed

• 48) Isobe, T. et al:Plasma cell leukemia. A clinical study of 13 cases, with a demonstration of small-sized plasma cells. Acta. Haem. Jap. 40:529-540, 1977.

• 49) 今村幸雄:多発性骨髄腫の診断. 臨床科学 7:913-926, 1971.

• 50) 今村幸雄:単クローン性免疫グロブリン血症の分類と特徴. 骨髄腫のすべて (三好和夫編) 17-34, 南江堂, 昭53.

• 51) Durie, B.G.M. et al:A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer 36:842-854, 1975.

• 52) 山崎健之ほか:多発性骨髄腫の治療. 臨床血液 10. 404-413, 1969.

• 53) 三好和夫ほか:骨髄腫の自然経過と治療. 臨床科学 7:949-957, 1971,

• 54) 太田宏ほか:血奨蛋白異常症-多発性骨髄腫を中心に-現代医学 23:297- 308, 1976.

• 55) Durie, B.G.M. et al:Synthesis and metabolism of Bence Jones protein and calculation of tumour burden in patients with Bence Jones myeloma. Brit. J. Haematol. 47:7-19, 1981.

• 56) Alexanian, R. et al:Prognostic factors in multiple myeloma. Cancer 36:1192-1201, 1975.
  pubmed

• 57) Johansson, B.:Prognostic factors in myelomatosis. Brit. Med. J.:327-328, 1971.
  pubmed

• 58) Merlini, G. et al:A new improved clinical staging system for multiple myeloma based on analysis of 123 treated patients. Blood 55:1011-1019, 1980.
  pubmed

• 59) Medical Research Council's Working Party for therapeutic trials in leukemia:Report on the first myelomatosis trial. Part 1. Analysis presenting features of prognostic importance. Brit. J. Haematol. 24:123-129, 1973.

• 60) Alexanian, R. et al:Melphalan therapy for plasma cell myeloma. Blood 31:1-10, 1968.
  pubmed

• 61) Durie, B.G.M. et al:Pretreatment tumor mass, cell kinetics, and prognosis in multiple myeloma Blood 55:364-372, 1980.

• 62) Drewinko, B. et al:The growth fraction of human myeloma cells, Blood 57:333-338, 1981.
  pubmed

• 63) Hansen, O.P.:Prognosis of myelomatosis on treatment with prednisone and cytostatics. Scand. J. Haematol. 10:282-290, 1973.
  pubmed

• 64) Hobbs, J.R.:Growth rates and response to treatment in human myelomatosis. Brit. J. Haematol. 16:607-617, 1969.

• 65) Kyle, R.A. et al:Effect of sodium fluoride, calcium carbonate, and vitamin D on the skeleton in multiple myeloma. Cancer 45:1669-1674, 1980.
  pubmed

• 66) 太田 宏ほか:治療. 骨髄腫のすべて (三好和夫編) 391-410, 南江堂. 昭53.

• 67) Medical Research Council:Myelomatosis:comparison of melphalan and cyclophosphamide therapy. Brit. Med. J. 1:640-641, 1971.

• 68) 今村幸雄:骨髄腫の治療とそれをめぐる諸問題. 日本医事新報 2944:3-13, 1980.

• 69) Bataille, R. et al:chimiotherapie du myelomme multiple des os:Aspects historiques et actuels Semin. Hop. Paris 55:1377-1382, 1979.

• 70) Salmon, S.E.:Immunoglobulin synthesis and tumor kinetics of multiple myeloma. Semin. Hematol. 10:135-147, 1973.
  pubmed

• 71) Drewinko, B. et al:Effect of chemotherapy on the laheling index of myeloma cells. Cancer 34:526-531, 1974.
  pubmed

• 72) Alberts, D.S. et al:DNA synthesis in multiple myeloma cells following cell cycle-nonsecific chemotherapy. Cancer Res. 34:2911-2914, 1974.

• 73) Hokanson, J.A. et al:Tumor growth patterns in multiple myeloma. Cancer 39:1077-1084, 1977.
  pubmed

• 74) Gonzalez, F.et al:Acute leukemia in multiple myeloma. Ann. Int. Med. 86:440-443, 1977.
  pubmed

• 75) Sullivan, P.W. et al:Kinetics of tumor growth and regression in IgG multiple myeloma. J. Clin Invest. 51:1697-1708, 1972.
  pubmed

• 76) Bergsagel, DE. et al:The chemotherapy of plasma cell myeloma and the incidence of acute leukemia N. Engl. J. Med. 301:743-748, 1979.
  pubmed

• 77) Committee of the Chronic Leukemia-Myeloma Task Force, National Cancer Institute.:Proposed guidelines for protocol studies. II. plasma cell myeloma. Cancer Chemother. Rep. 4 (part3):145-158, 1973.

• 78) 今村幸雄:多発性骨髄腫に対する化学療法の効果判定基準, 臨床血液 20: 677-680, 1979.

• 79) Waldenstrom, J.:Incipient myelomatosis or 《essential》 hypergammaglobulinemia with fibrinogenopenia-a new syndrome? Acta Med. Sc and. 117:216-247, 1944.

• 80) 三好和夫ほか:高蛋白血症の興味ある1例とその考察, 日血会誌 11:127-128, 昭23.

• 81) 今村幸雄:日本の Macroglobulinemia -臨床-綜合臨牀 22:1608-1615, 昭48.

• 82) MacKenzie, M.R. et al:Macroglobulinemia:An analysis for forty patients. Blood 39:874-889, 1972.
  pubmed

• 83) McCallister, B.D. et al:Primary macroglobulinemia:Review with a report on thirty-one cases and notes on the value of continuous chlorambucil therapy. Am J. Med. 43:393-434, 1967.

• 84) Yamaguchi, K.:Pathology of macroglobulinemia-a review of Japanese cases-Acta Path. Jap. 23:917-952, 1973.
  pubmed

• 85) Mackenzie, M.R. et al:Blood viscosity in Waldenstrom's macroglobulinemia. Blood 49:507-510, 1977.
  pubmed

• 86) Morel-Marger, L. et al:Pathology of the kidney in Waldenstrom's macroglobulinemia. Study of 16 cases N. Engl. J. Med. 283:123-127, 1970.

• 87) McGrath, MA. et al:Paraproteinemia. Blood hyperviscosity and clinical manifestations. J. Cin. Invest. 58:1155-1162, 1976.

• 88) Franklin, E.C. et al:Heavy chain disease-A new disorder of serum γ-globulins. Report of the first case. Am. J. Med. 37:332-350, 1964.

• 89) Seligmann, M. et al:Alpha-chain disease:A new immunoglobulin abnormality. Science 162:1396-1397, 1968.
  pubmed

• 90) Forte, F.A. et al:Heavy chain disese of the μ (γM) type:Report of the first case. Blood 36:137-144, 1970,

• 91) 今村幸雄:Heavy chain disease の臨床と病理. 日本臨牀 35:1653-1661, 昭52.

• 92) Tsuji, T.:Heavy-chain (Fc fragment) disease-lmmunological reactions of the first case in Japan and the incorporation of 14C-amino acids into the protein in vitro. Acta Haem. Jap. 33:89-99, 1970.

• 93) Buxbaum, J.N. et al.:Alpha and gamma heavy chain diseases in man:Intracellular origin of the aberrant polypeptides. J. Immunol. 109:1131-1137, 1972.
  pubmed

• 94) Frangione, B. et al.:Heavy chain disease:Clinical feature and molecular significance of the disordered immunoglobulin structure. Semin. Haematol. 10:53-64, 1973.

8. バンチ症候群

P.238 掲載の参考文献

• 1) Banti, G.:La splenomegalia con cirrosi epatica. Lo Sperimentale, Sez Biologica, 48:447, 1894.

• 2) Whipple, A.O.:The problem of portal hypertension in relation to the hepatosplenopathies. Ann. Surg., 122:449, 1945.

• 3) 今永 一:肝内循環よりみたる門脈圧亢進症の分類. 肝臓, 2:137, 1960.

• 4) Sherlock, S.:portal venous system and portal hypertension in "Disease of the liver and billary system." 5th ed. P. 189, Blackwell, Oxford, 1975.

• 5) 杉浦光雄:特発性門脈圧亢進症の手引, 治療指針. 厚生省特発性門脈圧亢進症調査研究班昭和52年度研究報告書. p.193, p.194, 1978.

• 6) 木谷健一:特発性門脈高圧症諸外国の症例, 診断及びその病態と病囚につい ての一考察. 肝臓, 19:1192, 1978.

• 7) Huet, P.M. et al.:Noncirrhotic presinusoidal portal hypertension associated with chronic arsenical intoxication. Gastroenterology, 68:1270, 1975.
  pubmed

• 8) Villeneneuve, J.P. et al.:Idiopathic portal Hypertension. Am. J. Surg., 61:459, 1976.

• 9) 小林連夫:全国集計による特発性門脈圧亢進症の疫学ならびに臨床実態に関する検討. 肝臓, 19:1198, 1978.

• 10) 岩城 篤他:特発性門脈圧亢進症の疫学ならびに臨床的特性に関する研究- 全国集計調査報告. 厚生省特発性門脈圧亢進症調査研究班 (班長 杉浦光雄), 昭和51年度研究報告書. p.16, 1977. 特発性門脈圧亢進症の経過と予後. 同 52年度研究報告書. p.26, 1978.

• 11) 友田正信:脾性中毒症. 金原出版, 東京, 1954.

• 12) 槙 哲夫, 佐藤寿雄他:わが国に於ける Banti 症候群研究の現況. 最新医学, 20:551, 1965.

• 13) 鈴木忠彦:門脈圧亢進症-病因と病理. 日外会誌, 57:987, 1956.

• 14) 志方俊夫他:いわゆる特発性門脈圧亢進症の成因に関する研究. 肝臓, 14:523, 1973.

• 15) 志方俊夫他:慢性肝炎と特発性門脈圧亢進症の接点にある症例の検討. 厚生省特発性門脈圧亢進症調査研究班 (班長 奥田邦雄) 昭和53年度研究報告書. p.20, 1979.

• 16) 武者広隆他:特発性門脈圧亢進症における肝癌の合併について. 厚生省特発性門脈圧亢進症調査研究班 (班長 奥田邦雄) 昭和53年度研究報告書. p.321, 1979.

• 17) 吉川和彦:特発性門脈圧亢進症の成因に関する研究-免疫学的機序の検討. 日外会誌, 79:528, 1978.

• 18) 梅山 馨他:特発性門脈圧亢進症 (バンチ症候群) の成因に関する考察-免 疫異常を伴う疾患の合併. 日消外会誌, 10:493, 1977.

• 19) 松塚文夫:慢性甲状腺炎と肝, 脾との関連性について-特にバンチ症候群と の合併例の検討. 福島医誌, 26:21, 1976.

• 20) 由井三郎:特発性門脈圧亢進症における末梢血リンパ球の Subpopulation とその機序. 阪市医誌, 28:409, 1979.

• 21) 西野光一:特発性門脈圧亢進症における抗リンパ球抗体の検索. 肝臓, 21(1) :74 速報, 1975.

• 22) Popper, H. et al.:Alteration of liver and spleen amog workers exp. osed to vinyl chloride. Ann. N. Y. Acad. Sci., 246:172, 1975.

• 23) Heusermann, U. und Stutte, HJ.:Enzymhistochemische, histometrische und ultrastrukturelle Untersuchungen von Milzen bei der Vinylchloride-Krankheit. Virchow Arch. A. Path. Anat. und Histol., 375:303, 1977.

• 24) 黄 河清:特発性門脈圧亢進症脾の電子顕微鏡的研究-とくに赤色髄につい て. 阪市医誌, 28:429, 1979.

• 25) 中田勝次他:バンチ脾のリンパ濾胞-とくにT, Bリンパ球の消長について, 厚生省特発性門脈圧亢進症調査研究班 (班長 杉浦光雄) 昭和52年度研究報告書. p.54, 1978.

• 26) 志方俊夫他:特発性門脈圧亢進症に於ける肝内異常血行路の研究. 肝臓, 18: 814, 1977.

• 27) 松本武四郎他:バンチ脾, 肝にみられる2, 3の形態的特徴. 原生省特発性門脈圧亢進症調査研究班 (班長 杉浦光雄) 昭和51年度研究, 報告書. p.60, 1977.

• 28) 高橋 豊:特発性門脈圧亢進症の脾腫と貧血 (血球減少) の治療. 綜合臨牀, 27:592, 1978.

• 29) 井口 潔:食道静脈瘤内視鏡所見記載基準. 肝臓, 21:779, 1980.

• 30) 吉本隆行他:門脈圧亢進症の超音波診断. 日超医論文集, 35:221, 1979.

• 31) 奥田邦雄:特発性門脈圧亢進症の脾腫, 貧血の治療について. 綜合臨牀, 27: 601, 1978.

• 32) Stricher, H.J. et al.:Die Milz, 1st ed., p.347, Springer Verlag, Berlin, 1970.

• 33) Likhite, V.V.:Immunological Impairment and Susceptbility to Infection After Splenectomy. JAMA, 236:1376, 1976.

• 34) Kiesewetter, W.B.:Pediatric Splenectomy, Indications, Technique, Complications and Mortality. Surg. Clin. Nor.Amer., 55:449, (1975).

• 35) 福田一雄他:Endotoxemia と食道静脈瘤内視鏡所見 (特に消化管出血との関連について). 日消誌, 76:1743, 1979.

• 36) 出月康夫他:食道静脈瘤破裂の救急処置と緊急手術の適応. 消化器外科, 2: 567, 1979.

• 37) Leveen, H.H. et al.:Peritoneo-venous shunting for ascites. Ann. Surg., 180:580, 1974.
  pubmed

• 38) 藤本泰久他:特発性門脈圧亢進症患者における末梢血リンパ球の Con A- induced suppressor cell の解析. 肝臓, 22:1036, 1981.

• 39) Landerquist, A. et al.:Follow up of patients with portal hypertension and esophageal varices treated with percutaneous obliteration of gastric coronary vein. Radiology, 122:59, 1977.
  pubmed

• 40) Yamamoto, K.:Morphorogical studies of the spleen in idiopathic portal hypertension (so-called Banti:s syndrome without liver cir. rhosis) using light microscopy, scanning electron microscopy and histometry. Acta Path. Jap., 29:1, 1979.

9. 網内系とその疾患

P.276 掲載の参考文献

• 1) Metchnikoff, E.:Legons sur la pathologie comparee de l'inflammation Masso, Paris. 1892.

• 2) Aschoff, L.:Das reticulo-endotheliale System. Erg. inn. Med. Kind-erheilk. 26:1-118, 1924.

• 3) Landau, M. & McNee, J.W.:Zur Physiologie des Cholesterinstoffwechsels. Beitr. Path. Anat. 58:667-692, 1914.

• 4) 清野謙次:生体染色の研究. 第2版. 南江堂, 1919.

• 5) 赤崎兼義:細網内皮系統とその腫瘍. 日病理会誌, 41:1-26, 1952.

• 6) 赤崎兼義:網内系研究の進歩, 日網会誌, 8:90-94, 1968.

• 7) Kojima, M.:Macrophages, reticuloendothelial system and mononu clear phagocyte system. Recent Advances in RES Research. 16:1-25, 1976.

• 8) van Furth, R., Cohn, Z.A., Hirsch, J.G., Humphrey, J.H., Spector, W.G. & Langevoort, H.L.:The mononuclear phagocyte system:anew classification of macrophages, monocytes and their precursor cells. Bull. Wld. Hlth. Org., 46:845-852, 1972.

• 9) van Furth, R. (Ed.):Mononuclear Phagocytes, Blackwell Scientific Publications, Oxford-Edingburgh, 1970.

• 10) van Furth, R. (Ed.):Mononuclear Phagocytes in Immunity, Infection and Pathology, Blackwell Scientific Publications, Oxford-Edinburgh-Melbourne, 1975.

• 11) van Furth, R. (Ed.):Mononuclear Phagocytes. Functional aspects. I. Martinus Nijhoff Publishers, Hauge-Boston-London. 1980.

• 12) Carr, I. & Daems, W.T.:The Reticuloendothelial System. A comprehensive treatise. I. Morphology. Plenum Press, New York, 1980.

• 13) Fujita, T.:Microarchitecture of reticular tissues. Reevaluation of the RES by scanning electron microscopy. Recent Advances in RES Research 18:1 19, 1978.

• 14) 高橋 潔:網内系をめぐる諸問題, リンパ学, 3:15-18, 1980.

• 15) 永井 裕, 許斐博史:細網線維の生化学, 日網会誌, 21:76, 1981.

• 16) Wisse, E.:Observation on the fine structure and peroxidase cytochemistry of nomal rat liver Kupffer cells. J. Ultrastruct. Res. 46:393-426, 1974.

• 17) 粟屋和彦:リンパ細網系細胞の系統発生, 日網会誌, 21:69, 1981.

• 18) Naito, M, Oka, Miyazaki, M, Sato, T. & Kojima, M.:Ultrastructural and cytochemical changes of monocyte and macrophages in vivo and in vitro. Recent Advances in RES Research 18:66-82, 1979.

• 19) Takahashi, K., Sakuma, H., Naito, M., Yaginuma, Y., Takahashi, H., Asano, S., Hojo, H. & Kojima, M.:Cytological characters, transformation and ontogenesis of dermal histiocytes and fibroblasts of rats. Acta Pathol. Jpn. 30:743-766, 1980.
  pubmed

• 20) 高橋 博:ラットの個体発生時における皮膚組織球の細胞学的研究. 日網会 誌, 21:27-50, 1981.

• 21) 内藤 真:肝造血におけるマクロファージ, 生体防御の機構 (II). 水野伝一 武谷健二, 石田名香雄編, 東京大学出版会. 35-52, 1981.

• 22) 小島 瑞, 高橋 潔:先天性網内系疾患, 文光堂, 東京. 1974.

• 23) Ward, P.A.:Leukotaxis and leukotactic disorders. Amer. J. Path. 77:520-538, 1974.
  pubmed

• 24) Stossel, T.P.:Phagocytosis. Clinical disorders of recognition and ingestion. Amer. J. Path. 88:741-752, 1977.
  pubmed

• 25) Weston, W.L.:Disorders of phagocyte function. Arch. Dermatol. 112:1589-1596, 1976.
  pubmed

• 26) Stossel, T.P.:Phagocytosis. New Engl. J. Med. 290:717-723, 774-800, 833-839, 1974.

• 27) Nelson, D.S. (Ed.):Immunobiology of the Macrophages. Academic Press, Inc. New York-San Francisco-London, 1976.

• 28) Nelson, D.S.:Macrophages and Immunity. North-Holland Publishing Co., Amsterdam-London, 1969.

• 29) Stuart, A.E.:The Reticuloendothelial System. E & S Livingstone, Edinburgh-London, 1970.

• 30) Dingle, J.T. & Fell, H.B. (Eds.):Lysosomes in Biology and Pathology, North-Holland Publishing Co. Amsterdam-London/American Elsevier Publishing Co., Inc. New York. 1969.

• 31) Dean, R.T. & Barrett, A.L:Lysomes. In Essays in Biochemistry. Vol. 12, (Eds.) Campbell P.N. & Aldridge, 1976.

• 32) Hers, H.G. & van Hoof, F. (Eds.):Lysosomes and Storage Diseases. Academic Press, Inc. New York-London, 1973.

• 33) Neufeld, E.F., Sando, G.N., Garvin, A.J. & Rome, L.H.:The transport of lysosomal enzymes. J. Supramolec. Struct. 6:95-101, 1977.
  pubmed

• 34) 臼井朋包, 山科郁男:化学増刊 73.複合糖質の代謝異常-その病態生化学-. 化学同人. 1977.

• 35) Cohn, Z.A.:Macrophage physiology. Fed. Proc. 34, 1725-1729, 1975.
  pubmed

• 36) Allison, A.C.:Mechanisms by which activated macrophages inhibit lymphocyte responses. Immunol. Rev. 40:3-27, 1978.
  pubmed

• 37) Nathan, C.F., Murray, H.W. & Cohn, Z.A.:The macrophage as an effector cell. New Engl. J. Med. 303:622-626, 1980.
  pubmed

• 38) North, R.J.:The concept of the activated macrophage. J. Immunol. 121:806-809, 1978.
  pubmed

• 39) Cohn, Z.A.:The activation of mononuclear phagocytes:Fact, fancy, and future. J. Immunol. 121:813-816, 1978.
  pubmed

• 40) Davies, P. & Allison, A.C.:The macrophage as a secretory cell in chronic inflammation. Agents & Actions, 6:60-74, 1976.
  pubmed

• 41) 田中 渥:細菌細胞壁成分による類上皮細胞肉芽腫形成について. 日病会誌, 70 補 (2):18, 1981.

• 42) 小島 瑞, 高橋 潔:蓄積性細網内皮症, 白血病および類縁疾患II, 新版日本血液学全書 6. 711-774, 1979.

• 43) 小島 瑞, 高橋 潔:網内系腫瘍の病理-新しい観点からの考察-, 日本臨牀, 39:2613-2624, 1981.
  Medical*Online

• 44) 高橋 潔, 内藤 真, 高橋 博:組織球性腫瘍ならびに増殖症の電顕病理学 的解析, 細胞, 13:319-326, 1981.

• 45) 高橋 潔, 内藤 真:マクロファージの病理-その腫瘍性増殖を中心とし て-:第2回浜松免疫セミナー 「マクロファージの分化と機能」 メディカルリサーチ・センター, 東京, 1982.

• 46) Kojima, M.:Tumor growthof the reticuloendothelial system. Acta Path. Jap. 26:

• 47) Scott, R.B. & Robb-Smith, A.H.T.:Histiocytic medullary reticulosis. Lancet 2:194-198, 1939.

• 48) Rappaport, H.:Malignant histiocytosis. In Tumors of the Hematopoietic System. Section III. Fascicle 8. Atlas of Tumor Pathology. AFIP., p. 49-63, 1966.

• 49) Byne, G. & Rappaport, H.:Malignant histiocytosis. Gann Monograph of Cancer Research. 15:145-162, 1973.

• 50) Robb-Smith, A.H.T. & Taylor, C.R.:Lymph Node Biopsy. A diagnostic atlas. Miller-Heyden. London. 1981.

• 51) Lichtenstein, L.:Histiocytosis X. Integration of eosinophilic granuloma of bone, Letterer-Siwe disease and Hand-Schuller-Christian disease as related manifestation of a single nosologic entity. Arch. Pathol. 56:84-102, 1953.
  pubmed

• 52) Farquhar, J.W. & Claireaux, A.R.:Familial haemophagocytic reticulosis. Arch. Dis. Childh. 27:519-525, 1952.

• 53) Ewing, J.:Diffuse endothelioma of bone. Proc. N.Y. Path. Soc. 21:17-24, 1921.

• 54) Oberling, Ch. & Raileanu, C.:Nouvelles reserches sur les reticuloen dotheliosarcome de la moelle osseuse (sarcome d"Ewing) Bull. Ass. Frang. Cancer 21:333-342, 1926.

• 55) Lukes, RJ. & Parker, J.W.:The pathology of lymphoreticular neoplasms. In Comprehensive Immunology 4:The Immunopathology of Lymphoreticular Neoplasms. Towmey, JJ. & Good, R.A., Plenum Medical Book Co., New York-London, p.239-279, 1978.

• 56) Ozzello, L, Stout, A.P., & Murrary, MR.:Cultural characteristic of malignant histiocytomas and fibrous xanthomas. Cancer 16:331-344, 1963.